A phase 3 trial of Immunovant’s FcRn inhibitor batoclimab has hit its primary endpoint. But, having made a second-generation molecule its lead candidate last year, the biotech isn’t currently ...

President Donald Trump signed an executive order targeting the law firm of Jenner and Block over the role of a former partner at the firm who aided onetime special counsel Robert Mueller’s ...

In today's big story, BI uncovered Meta's secret "block lists" — and it turns out ... Read the full story. 3 things in markets 1. Interest rates steady; stagflation fears up.